Enact Holdings Inc
NASDAQ:ACT
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
26.45
36.99
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
ACT Price Targets Summary
Enact Holdings Inc
According to Wall Street analysts, the average 1-year price target for ACT is 39.47 USD with a low forecast of 35.86 USD and a high forecast of 44.1 USD.
ACT Last Price Targets
Enact Holdings Inc
The latest public price target was made on May 21, 2024 by Doug Harter from UBS , who expects ACT stock to rise by 1% over the next 12 months. You can read more about this price target by viewing the article on TheFly.
Analyst | Price Target | Date | Article |
---|---|---|---|
Doug Harter
UBS
|
33
USD
Upside 1% |
7 months ago
May 21, 2024
|
Enact Holdings price target raised to $33 from $31 at UBS
TheFly
|
Soham Bhonsle
BTIG
|
33
USD
Upside 1% |
7 months ago
May 6, 2024
|
Enact Holdings price target raised to $33 from $30 at BTIG
TheFly
|
Unknown Analyst
J.P. Morgan
|
25
USD
Downside 24% |
1 year ago
Feb 8, 2023
|
JP Morgan Maintains Neutral on Enact Holdings, Lowers Price Target to $25
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ACT's stock price target?
Price Target
39.47
USD
According to Wall Street analysts, the average 1-year price target for ACT is 39.47 USD with a low forecast of 35.86 USD and a high forecast of 44.1 USD.
What is Enact Holdings Inc's Revenue forecast?
Projected CAGR
5%
For the last 4 years the compound annual growth rate for Enact Holdings Inc's revenue is 4%. The projected CAGR for the next 3 years is 5%.
What is Enact Holdings Inc's Net Income forecast?
Projected CAGR
1%
For the last 4 years the compound annual growth rate for Enact Holdings Inc's net income is 0%. The projected CAGR for the next 3 years is 1%.